v3.25.2
Statements of Consolidated Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Stock Options and Stock Appreciation Rights [ Member]
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Stock Options and Stock Appreciation Rights [ Member]
Additional Paid-in Capital
Performance Shares [Member]
Additional Paid-in Capital
Restricted Stock Units (RSUs) [Member]
Retained Earnings
Treasury Shares- at Cost
Treasury Shares- at Cost
Stock Options and Stock Appreciation Rights [ Member]
Treasury Shares- at Cost
Performance Shares [Member]
Treasury Shares- at Cost
Restricted Stock Units (RSUs) [Member]
Accumulated Other Comprehensive Income (Loss)
Parent [Member]
Parent [Member]
Stock Options and Stock Appreciation Rights [ Member]
Parent [Member]
Performance Shares [Member]
Parent [Member]
Restricted Stock Units (RSUs) [Member]
Beginning balance, shares at Jun. 30, 2022     38,499                            
Beginning balance at Jun. 30, 2022     $ 10,000 $ 183,822       $ 1,499,676 $ (471,848)       $ (72,295) $ 1,149,355      
Net income $ 346,739                         346,739      
Other comprehensive income (loss) $ 16,999                       16,999 16,999      
Cash dividends per share $ 1.38                                
Cash dividends - $1.38, $1.44, and $1.66 per share for 2023, 2024, and 2025 respectively               (53,887)           (53,887)      
Purchases of common stock for treasury, shares     (8)                            
Purchases of common stock for treasury                 (716)         (716)      
Treasury shares issued for:                                  
Exercise of stock appreciation rights and options, shares     92                            
Additional Paid in Capital, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units         $ (4,256) $ (1,290) $ (1,712)                    
Stock Issued During Period, Value, Stock Options Exercised                   $ (3,773)              
Performance share awards, shares     23                            
Performance share awards                     $ (758)            
Restricted stock units, shares     34                            
Restricted stock units                       $ (932)          
Total Shareholders' Equity, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units                             $ (8,029) $ (2,048) $ (2,644)
Compensation expense       9,576 2,785                 9,576 2,785    
Other, shares     17                            
Other       (279)       104 482         307      
Ending balance, shares at Jun. 30, 2023     38,657                            
Ending balance at Jun. 30, 2023     $ 10,000 188,646       1,792,632 (477,545)       (55,296) 1,458,437      
Net income $ 385,762                         385,762      
Other comprehensive income (loss) $ (22,270)                       (22,270) (22,270)      
Cash dividends per share $ 1.44                                
Cash dividends - $1.38, $1.44, and $1.66 per share for 2023, 2024, and 2025 respectively               (56,560)           (56,560)      
Purchases of common stock for treasury, shares     (398)                            
Purchases of common stock for treasury                 (73,388)         (73,388)      
Treasury shares issued for:                                  
Exercise of stock appreciation rights and options, shares     73                            
Additional Paid in Capital, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units         (3,611) (3,072) (905)                    
Stock Issued During Period, Value, Stock Options Exercised                   (3,886)              
Performance share awards, shares     54                            
Performance share awards                     (3,487)            
Restricted stock units, shares     16                            
Restricted stock units                       (1,108)          
Total Shareholders' Equity, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units                             (7,497) (6,559) (2,013)
Compensation expense       9,496 3,448                 9,496 3,448    
Other, shares     7                            
Other       (224)       4 145         (75)      
Ending balance, shares at Jun. 30, 2024 38,409   38,409                            
Ending balance at Jun. 30, 2024 $ 1,688,781   $ 10,000 193,778       2,121,838 (559,269)       (77,566) 1,688,781      
Net income 392,988                         392,988      
Other comprehensive income (loss) $ (14,120)                       (14,120) (14,120)      
Cash dividends per share $ 1.66                                
Cash dividends - $1.38, $1.44, and $1.66 per share for 2023, 2024, and 2025 respectively               (66,910)           (66,910)      
Purchases of common stock for treasury, shares     (656)                            
Purchases of common stock for treasury                 (153,390)         (153,390)      
Treasury shares issued for:                                  
Exercise of stock appreciation rights and options, shares   82 36                            
Additional Paid in Capital, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units         (2,110) $ (2,213) $ (2,301)                    
Stock Issued During Period, Value, Stock Options Exercised                   $ (2,710)              
Performance share awards, shares     34                            
Performance share awards                     $ (3,294)            
Restricted stock units, shares     41                            
Restricted stock units                       $ (2,116)          
Total Shareholders' Equity, Exercise of stock appreciation rights and options, Performance share awards, Restricted stock units                             (4,820) $ (5,507) $ (4,417)
Compensation expense       7,289 $ 4,713                 7,289 $ 4,713    
Other, shares     4                            
Other       (186)       15 84         (87)      
Ending balance, shares at Jun. 30, 2025 37,868   37,868                            
Ending balance at Jun. 30, 2025 $ 1,844,520   $ 10,000 $ 198,970       $ 2,447,931 $ (720,695)       $ (91,686) $ 1,844,520